Icu Medical (ICUI) EBITDA (2009 - 2026)

Icu Medical (ICUI) has 18 years of EBITDA data on file, last reported at $13.6 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 5.36% year-over-year to $13.6 million; the trailing twelve-month figure through Mar 2026 stood at $43.5 million (down 34.56% YoY), and the FY2025 full-year result was $42.8 million, changed 0.31% from the prior year.
• EBITDA for Q1 2026 stood at $13.6 million, up from $5.6 million in the prior quarter.
• Across five years, EBITDA topped out at $37.7 million in Q4 2024 and bottomed at -$42.2 million in Q1 2022.
• The 5-year median for EBITDA is $7.7 million (2024), against an average of $4.7 million.
• Peak annual rise in EBITDA reached 5850.0% in 2023, while the deepest fall reached 5387.84% in 2023.
• A 5-year view of EBITDA shows it stood at -$222000.0 in 2022, then sank by 5387.84% to -$12.2 million in 2023, then soared by 409.37% to $37.7 million in 2024, then plunged by 85.05% to $5.6 million in 2025, then jumped by 140.98% to $13.6 million in 2026.
• The last three EBITDA figures came in at $13.6 million (Q1 2026), $5.6 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.

Peer Comparison